Evidence map›Paper›PMID 40544400›Full record

ArticleBioprocess and biosystems engineering2025

Aesculus hippocastanum extract-mediated biosynthesis of silver-decorated zinc oxide nanoparticles and investigation of their photocatalytic, antibacterial, and antioxidant properties.

Sobhan Mortazavi-Derazkola, Maryam Samadipour, Pouria Mohammadparast-Tabas, Masoud Yousefi

Abstract read
PubMed Publisher
In one paragraph

Article in Bioprocess and biosystems engineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sobhan Mortazavi-DerazkolaMedical Toxicology and Drug Abuse Research Center (MTDRC), Birjand University of Medical Sciences, Birjand, Iran.
Maryam SamadipourStudent Research Committee, Birjand University of Medical Sciences, Birjand, Iran.
Pouria Mohammadparast-TabasStudent Research Committee, Birjand University of Medical Sciences, Birjand, Iran.
Masoud YousefiDepartment of Medical Microbiology, School of Medicine, Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran. masoud.yousefi164@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this research, silver-decorated zinc oxide nanoparticles (ZnO-Ag NPs) were fabricated using Aesculus hippocastanum fruit extract (ZnO-Ag@AHFE NPs), and their catalytic and antimicrobial properties were studied. The nanoparticles were identified using XRD, TEM, and FT-IR analyses, which confirmed their spherical morphology, uniform structure, and particle sizes ranging from 50 to 70 nm. The ZnO-Ag@AHFE NPs illustrated high antibacterial performance compared to the extract and ZnO NPs alone, achieving a minimum inhibitory concentration (MIC) of 125 µg/mL against Escherichia coli and Pseudomonas aeruginosa. Additionally, the ZnO-Ag@AHFE NPs exhibited outstanding photocatalytic efficiency, degrading methylene blue and rhodamine B dyes by 97.6% and 94.3%, respectively, surpassing the performance of other catalysts. Antioxidant assays revealed that the nanoparticles inhibited 85% of DPPH free radicals, underscoring their potential in biological applications. This study presents a green method using A. hippocastanum fruit extract, offering an innovative approach to enhance the antibacterial, catalytic, and antioxidant properties of ZnO-Ag NPs. These findings highlight the transformative potential of green synthesis strategies for the development of multifunctional nanomaterials.

Indexed as

Anti-Bacterial AgentsAntioxidantsMetal NanoparticlesPlant ExtractsSilverZinc OxideCatalysisEscherichia coliMicrobial Sensitivity TestsPseudomonas aeruginosaAnti-Bacterial AgentsAntioxidantsPlant ExtractsSilverZinc OxideAesculus hippocastanumAntibacterialCatalyticGreen synthesisSilverZinc oxide

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.